All In MedTech

Device Trial Radar · NCT04207554

Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test

Last checked: Nov 21, 2026Latest source record: Jan 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

132

Actual

Start

Dec 5, 2019

Primary completion

Dec 29, 2020

Study completion Dec 29, 2020

Sponsor

Lead sponsor
Guangzhou Wondfo Biotech Co., LtdNot on our public-company list
Sponsor type
Industry
Collaborators
Nova Clinical Solutions, Inc.
First posted
Dec 23, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the agreement of the test device (Preview® hCG Urine/Serum Combo Pregnancy Test) with the predicate device, the QuickVue+ hCG Combo Test.

Conditions

  • Pregnancy

Interventions

  • Test Device-Strip FormatDevice

    Sponsor's investigational device

  • Test Device-Cassette FormatDevice

    Sponsor's investigational device

  • Predicate DeviceDevice

    Commercially available device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall percent (%) agreementTime frame: 3 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • National Insitute of Clinical Research

    Garden Grove, California

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.